Purpose: Second malignant neoplasms (SMNs) after diagnosis of childhood acute lymphoblastic leukemia (ALL) are rare events. Patients and Methods: We analyzed data on risk factors and outcomes of 642 children with SMNs occurring after treatment for ALL from 18 collaborative study groups between 1980 and 2007. Results: Acute myeloid leukemia (AML; n 186), myelodysplastic syndrome (MDS; n 69), and nonmeningioma brain tumor (n 116) were the most common types of SMNs and had the poorest outcome (5-year survival rate, 18.1% ± 2.9%, 31.1% ± 6.2%, and 18.3% ± 3.8%, respectively). Five-year survival estimates for AML were 11.2% ± 2.9% for 125 patients diagnosed before 2000 and 34.1% ± 6.3% for 61 patients diagnosed after 2000 (P
CITATION STYLE
Schmiegelow, K., Levinsen, M. F., Attarbaschi, A., Baruchel, A., Devidas, M., Escherich, G., … Valsecchi, M. G. (2013). Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 31(19), 2469–2476. https://doi.org/10.1200/JCO.2012.47.0500
Mendeley helps you to discover research relevant for your work.